ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,778.31
1.15%
US Tech 100
19,675.60
1.21%
다우존스 지수
42,182.36
0.93%
Bitcoin
69,476.49
2.44%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. MacroGenics Inc (MGNX)

  7. MacroGenics Inc (MGNX) 뉴스

MacroGenics Inc

MacroGenics Inc (MGNX)

NASDAQ
3.835
0.135
( 3.65% )
업데이트: 05:41:03
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

MGNX 뉴스

공식 뉴스 전용

Form 8-K - Current report
Edgar (US Regulatory)
30 10월 2024
MGNX (3.65%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
10 10월 2024
MGNX (3.65%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
26 9월 2024
MGNX (3.65%)

Form 8-K - Current report
Edgar (US Regulatory)
17 9월 2024
MGNX (3.65%)

MGNX Discussion

게시물 보기
Monksdream Monksdream 1 월 전
MGNX new 52 week low
👍️0
Monksdream Monksdream 1 월 전
MGNX new 52 week low
👍️0
Money Management Money Management 5 월 전
Lucy runs
👍️0
Dubster watching Dubster watching 6 월 전
Blessings sir!
👍️0
Tom turtles Tom turtles 6 월 전
Well, I never got in. Thought it might of seen upper twos today. Watched it go up 30% though. Got in AMC for some reason. Glad someone made some money here.
👍️0
Dubster watching Dubster watching 6 월 전
I thought I was going to take a loss on my bottom feeding expedition, but instead I am thankful that He blesses me!
👍️0
Dubster watching Dubster watching 6 월 전
Bingo
👍️0
Dubster watching Dubster watching 6 월 전
Finally sold some greened up.
I wait until the issues aren’t deaths
👍️0
Tom turtles Tom turtles 6 월 전
$2.50 Monday ?
👍️0
Dubster watching Dubster watching 6 월 전
These guys are getting hammered! 75%
👍️0
Dubster watching Dubster watching 6 월 전
Down 75% this should be wild today!
👍️0
Dubster watching Dubster watching 6 월 전
Took a starter, gotta gave a bounce here.
👍️0
Dubster watching Dubster watching 6 월 전
Interesting drop today.
Hunting
👍️0
stocksrising stocksrising 6 월 전
I’m with ya on entry..planning on a $3ish handle which equals cash on balance sheet( ~ $185mm ish)…. Will do starter in low $4’s(minor $$, then DCA if $3’s ( much more $) …back up truck if deaths not related to clinical’s after internal investigation)
👍️0
Tom turtles Tom turtles 6 월 전
Well, 5 fatalities ready didn't help...geez...Looking for entry
👍️0
Monksdream Monksdream 8 월 전
MGNX new 52 week high
👍️0
Monksdream Monksdream 8 월 전
MGNX new 52 week high
👍️0
Monksdream Monksdream 9 월 전
MGNX new 52 week high
K
👍️0
Monksdream Monksdream 9 월 전
MGNX new 52 week high
👍️0
Monksdream Monksdream 9 월 전
MGNX
👍️0
Monksdream Monksdream 10 월 전
MGNX new 52 week high
👍️0
Monksdream Monksdream 10 월 전
MGNX new 52 week high
👍️0
ipo_dude ipo_dude 10 월 전
Lets do this . Can it keep going
👍️0
MiamiGent MiamiGent 11 월 전
MGNX $10.71 +1.48 (+16.03%)
Nice steady climb, as shorts writhe and wail
👍️0
MiamiGent MiamiGent 11 월 전
MGNX I'm going with this
$10.50 +1.27 (+13.76%)
It's a bit of a bail, as I have other work to catch up on
Squeeze of 13% short, on a Citi upgrade to $13

Could turn into a several days hold, for incremental gains. Maybe 5% more today??

https://stockcharts.com/h-sc/ui?s=MGNX

Citigroup Upgrades Macrogenics to Buy, Raises Price Target to $13
BENZINGA 4:20 AM ET Dec-20-2023

Citigroup analyst Yigal Nochomovitz upgrades Macrogenics (MGNX.NaE) from Neutral to Buy and raises the price target from $7 to $13.


Company Profile
SectorHealth CareOpens in a new window
IndustryBiotechnologyOpens in a new window
Company LocationRockville, MD
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 x CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. In addition, i
👍️0
ipo_dude ipo_dude 11 월 전
👀
👍️0
ipo_dude ipo_dude 11 월 전
Shes ready to pop above $10
👍️0
XenaLives XenaLives 2 년 전
Historic short interest:

You can go to this link to check short interest in a stock:
http://nasdaqtrader.com/Trader.aspx?id=ShortInterest

Publication schedule is here:
http://nasdaqtrader.com/Trader.aspx?id=ShortIntPubSch


Settlement Date/Short Interest/Percent Change/
Average Daily Share Volume/Days to Cover

01/13/2023 4,373,837 5.28 507,089 8.63
12/30/2022 4,154,346 7.91 575,736 7.22
12/15/2022 3,849,672 (5.66) 633,050 6.08
11/30/2022 4,080,607 (4.36) 1,384,683 2.95
11/15/2022 4,266,434 (15.78) 1,093,099 3.90
10/31/2022 5,065,570 2.50 1,487,531 3.41
10/14/2022 4,942,015 (0.29) 379,450 13.02
09/30/2022 4,956,490 1.85 563,681 8.79
09/15/2022 4,866,500 (0.81) 635,807 7.65
08/31/2022 4,905,995 (13.08) 631,036 7.77
08/15/2022 5,644,366 (0.09) 971,172 5.81
07/29/2022 5,649,639 (17.42) 1,065,799 5.30
07/15/2022 6,841,233 (10.73) 1,407,012 4.86
06/30/2022 7,663,135 (0.99) 2,692,200 2.85
06/15/2022 7,739,527 27.13 1,239,553 6.24
05/31/2022 6,088,004 8.28 827,523 7.36
05/13/2022 5,622,390 10.78 1,337,461 4.20
04/29/2022 5,075,315 3.20 453,486 11.19
04/14/2022 4,917,910 (4.48) 509,771 9.65
03/31/2022 5,148,635 3.46 522,723 9.85
03/15/2022 4,976,392 36.20 868,105 5.73
02/28/2022 3,653,830 4.57 898,618 4.07
02/15/2022 3,494,052 19.83 571,075 6.12
01/31/2022 2,915,828 7.17 457,915 6.37
👍️0
XenaLives XenaLives 2 년 전
So what exactly did MGNX do to this diabetes drug?


MacroGenics to get $60M milestone from Provention as FDA approves diabetes drug Tzield


More homework:
https://patents.justia.com/assignee/macrogenics-inc
👍️0
XenaLives XenaLives 2 년 전
Looking at MGNX because the chart is intriguing..

VBP is consolidating nicely...

👍️0
XenaLives XenaLives 2 년 전
Now I need to figure out what DART and TRIDENT are...


Nov 17, 2022
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
ROCKVILLE, MD, Nov. 17, 2022 (GLOBE NEWSWIRE) --

MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today reported that the U.S. Food and Drug Administration announced the approval of the Biologics License Application (BLA) for teplizumab, an anti-CD3 monoclonal antibody that was previously developed by MacroGenics. Teplizumab was acquired by Provention Bio, Inc. in May 2018 pursuant to an asset purchase agreement.

“We are very pleased to see the culmination of years of effort by Provention, MacroGenics, and tireless champions in academia and government, with the achievement of the approval of teplizumab,” said Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics. “We applaud this outcome, which represents an advancement for individuals and their families dealing with the risks and consequences of type 1 diabetes.”

Under the agreement, Provention is obligated to pay MacroGenics contingent milestone payments totaling $170 million upon the achievement of certain regulatory approval milestones, including $60 million for the approval of a BLA for a first indication in the United States. In addition, Provention is obligated to make contingent milestone payments to MacroGenics totaling $225 million upon the achievement of certain sales milestones as well as a single-digit royalty on net sales of the product.

Based on MacroGenics’ cash, cash equivalents and marketable securities balance as of September 30, 2022, plus projected and anticipated payments from partners, including timely receipt of the milestone payment from Provention, MacroGenics currently anticipates having a cash runway into late 2024.


http://ir.macrogenics.com/news-releases/news-release-details/macrogenics-and-zai-lab-enter-broad-strategic-collaboration
👍️0
XenaLives XenaLives 2 년 전
Nov 17, 2022
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
ROCKVILLE, MD, Nov. 17, 2022 (GLOBE NEWSWIRE) --

MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today reported that the U.S. Food and Drug Administration announced the approval of the Biologics License Application (BLA) for teplizumab, an anti-CD3 monoclonal antibody that was previously developed by MacroGenics. Teplizumab was acquired by Provention Bio, Inc. in May 2018 pursuant to an asset purchase agreement.

“We are very pleased to see the culmination of years of effort by Provention, MacroGenics, and tireless champions in academia and government, with the achievement of the approval of teplizumab,” said Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics. “We applaud this outcome, which represents an advancement for individuals and their families dealing with the risks and consequences of type 1 diabetes.”

Under the agreement, Provention is obligated to pay MacroGenics contingent milestone payments totaling $170 million upon the achievement of certain regulatory approval milestones, including $60 million for the approval of a BLA for a first indication in the United States. In addition, Provention is obligated to make contingent milestone payments to MacroGenics totaling $225 million upon the achievement of certain sales milestones as well as a single-digit royalty on net sales of the product.

Based on MacroGenics’ cash, cash equivalents and marketable securities balance as of September 30, 2022, plus projected and anticipated payments from partners, including timely receipt of the milestone payment from Provention, MacroGenics currently anticipates having a cash runway into late 2024.

https://www.globenewswire.com/news-release/2022/11/17/2558767/0/en/MacroGenics-Earns-60-Million-Milestone-with-U-S-FDA-Approval-of-Teplizumab.html
👍️0
makinezmoney makinezmoney 2 년 전
$MGNX: What did I tell ya........ hit $4.15 !!!!!!!!!


MUAHHHHhhhhhhhhhh ha ha ha ha ha haaaaaaaaaAAAAAAAAAAAAAA



LOVE IT when a plan comes together like that


Looking for more winners............ stand by


GO $MGNX
👍️0
makinezmoney makinezmoney 2 년 전
$MGNX: Perfeccccccttttttttt Cup & Handle here at 3.50


Added 10k shares here


Get to $4 !!!!!!!!


GOO $MGNX
👍️0
ipo_dude ipo_dude 4 년 전
Where do we go from here?
👍️0
Now516 Now516 4 년 전
FDA approval: https://www.macrogenics.com/news/macrogenics-announces-fda-approval-of-margenza-for-patients-with-pretreated-metastatic-her2-positive-breast-cancer/
👍️0
Glider549 Glider549 4 년 전
https://biopharmcatalyst.us13.list-manage.com/track/click?u=ce642b003b32103d28995373d&id=a988dba9aa&e=d1924831d6
👍️0
rsconcept rsconcept 4 년 전
SCAM ALERT, be careful the SEC must be looking at it as we speak.
This is a $13-$16 stock at best.
👍️0
rsconcept rsconcept 4 년 전
https://newsnation1.com/macrogenics-inc-mgnx-scam-news/
👍️0
ClayTrader ClayTrader 4 년 전
* * $MGNX Video Chart 05-11-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
Hercules1 Hercules1 4 년 전
$MGNX:

Nice to see shorts getting killed here.

Go ahead short some more you cowards.
👍️0
ClayTrader ClayTrader 4 년 전
* * $MGNX Video Chart 05-07-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
davidsson10 davidsson10 5 년 전
+$$$ MGNX

Successful lifestyle enhancement trading.....
👍️0
ClayTrader ClayTrader 5 년 전
* * $MGNX Video Chart 05-06-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
rsconcept rsconcept 5 년 전
great, lets short it again!
👍️0
crudeoil24 crudeoil24 5 년 전
Investors are forward looking, especially into company pipeline.
👍️0
PAC PAC 5 년 전
What i say? Retest after shakeout 19s
👍️0
crudeoil24 crudeoil24 5 년 전
We all ran with this from earlier today. Shorts will have their cluster rama rally now. GLTY.
👍️0
godofthestock godofthestock 5 년 전
TIMBER!!!!!!!


IMO
👍️0
godofthestock godofthestock 5 년 전
This is going to be great IMO
👍️0

최근 히스토리

NASDAQ
MGNX
MacroGenics
EU
BPHAV
BNP Paribas Home Loan SF...
COIN
TOTOUSD
TouristToken
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유